BlueLinx (BXC) PT Lowered to $100 at DA Davidson
Get Alerts BXC Hot Sheet
Price: $70.76 -0.74%
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
DA Davidson analyst Michael Shlisky lowered the price target on BlueLinx (NYSE: BXC) to $100.00 (from $105.00) while maintaining a Buy rating.
You May Also Be Interested In
- Teva Pharma (TEVA) PT Raised to $52 at Oppenheimer
- Envista Holdings Corp. (NVST) PT Lowered to $26 at Piper Sandler
- RPM International (RPM) PT Lowered to $117 at KeyBanc
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share